Weld Gwen E has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 160000 shares of Nautilus Biotechnology, Inc. ($NAUT) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Nautilus Biotechnology, Inc. | $NAUT | Weld Gwen E | Chief People Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 126,305,122 | 9999.99% | 0.13% |
| March 3, 2025 | Nautilus Biotechnology, Inc. | $NAUT | Weld Gwen E | Chief People Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 126,148,469 | 9999.99% | 0.13% |
| March 1, 2024 | Nautilus Biotechnology, Inc. | $NAUT | Weld Gwen E | Chief People Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | Nautilus Biotechnology, Inc. | $NAUT | Weld Gwen E | Chief People Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |